📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Characterisation of a cyclic peptide that binds to the RAS binding domain of phosphoinositide 3-kinase p110a. (2023)

First Author: Ismail M

Attributed to: Cancer drug discovery targeting the interaction of RAS oncogenic proteins with phosphoinositide 3-kinase funded by UKRI Inn.Scholar

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41598-023-28756-0

PubMed Identifier: 36732563

Publication URI: http://europepmc.org/abstract/MED/36732563

Type: Journal Article/Review

Volume: 13

Parent Publication: Scientific reports

Issue: 1

ISSN: 2045-2322